Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 497 | N/A | N/A |
| Other current assets | 37 | 0 | 0 | 293 | 0 |
| TOTAL | $46 | $81 | $1,098 | $293 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 6,669 | 19,901 | 299,084 | 0 | 0 |
| TOTAL | $6,669 | $19,901 | $299,084 | $N/A | $N/A |
| Total Assets | $6,714 | $19,982 | $300,182 | $293 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,761 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,390 | 391 | 303 | 0 | 0 |
| Accrued Expenses | N/A | N/A | N/A | 55 | N/A |
| TOTAL | $15,616 | $403 | $303 | $294 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,669 | 19,901 | 309,817 | 0 | 0 |
| TOTAL | $6,669 | $19,901 | $309,817 | $N/A | $N/A |
| Total Liabilities | $22,285 | $20,305 | $310,120 | $294 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,901 | 8,991 | 35,938 | N/A | N/A |
| Common Shares | 1 | 1 | 1 | 1 | N/A |
| Retained earnings | -24,374 | -11,288 | -9,939 | -26 | N/A |
| TOTAL | $-15,570 | $-322 | $-9,938 | $-1 | $N/A |
| Total Liabilities And Equity | $6,714 | $19,982 | $300,182 | $293 | $0 |